Stockscreener 앱 받기
37.54
1.93%
-0.74
시간 외 거래:
37.54
Xenon Pharmaceuticals Inc 주식(XENE)의 최신 뉴스
Xenon Pharmaceuticals to Announce Q1 2025 Financial Results - TipRanks
Xenon to Report Q1 2025 Financial Results on May 12, 2025 - The Manila Times
Xenon Q1 Earnings Preview: Key Updates Expected on Breakthrough Epilepsy Drug Azetukalner - Stock Titan
Wall Street Analysts See a 48.15% Upside in Xenon Pharmaceuticals (XENE): Can the Stock Really Move This High? - Yahoo Finance
(XENE) On The My Stocks Page - news.stocktradersdaily.com
Renaissance Technologies LLC Decreases Stake in Xenon Pharmaceuticals Inc. (NASDAQ:XENE) - Defense World
Xenon Pharmaceuticals (NASDAQ:XENE) Stock Rating Lowered by StockNews.com - Defense World
Xenon Pharmaceuticals Reports Inducement Grants Under Nasdaq Listing Rule 5635(c)(4) | XENE Stock News - GuruFocus
Xenon Pharmaceuticals Announces Equity Inducement Grants to New Employees - TipRanks
Xenon Pharmaceuticals Reports Inducement Grants Under Nasdaq Listing Rule 5635(c)(4) - The Manila Times
Xenon Pharmaceuticals Expands Team with $3M Equity Package: 78,600 Options Granted to New Hires - Stock Titan
This trade activity should not be overlooked: Xenon Pharmaceuticals Inc (XENE) - Sete News
Upward Trajectory: Xenon Pharmaceuticals Inc (XENE) Posts a Slidee, Closing at 38.20 - DWinneX
Xenon Pharmaceuticals Target of Unusually Large Options Trading (NASDAQ:XENE) - Defense World
Xenon Pharmaceuticals Inc [XENE] MORTIMER IAN sells 22,468 Shares for $0.9 million - knoxdaily.com
Geode Capital Management LLC Purchases 720 Shares of Xenon Pharmaceuticals Inc. (NASDAQ:XENE) - Defense World
Envestnet Asset Management Inc. Sells 1,539 Shares of Xenon Pharmaceuticals Inc. (NASDAQ:XENE) - Defense World
Press Release Distribution & PR Platform - ACCESS Newswire
Xenon Pharmaceuticals Inc (NASDAQ:XENE)’s 12-Month Price Target Currently Stands At 42 - Marketing Sentinel
StockNews.com Upgrades Xenon Pharmaceuticals (NASDAQ:XENE) to Hold - Defense World
Wells Fargo & Company MN Reduces Holdings in Xenon Pharmaceuticals Inc. (NASDAQ:XENE) - Defense World
Xenon Pharmaceuticals Inc. (NASDAQ:XENE) Receives Average Recommendation of “Buy” from Analysts - Defense World
Market Insights: Xenon Pharmaceuticals Inc (XENE)’s Notable Gain of 2.34, Closing at 37.59 - DWinneX
Xenon Pharmaceuticals Inc (XENE) is an excellent investment, but the stock is overvalued/undervalued right now - uspostnews.com
Xenon Pharmaceuticals (NASDAQ:XENE) Upgraded by StockNews.com to Hold Rating - Defense World
When (XENE) Moves Investors should Listen - news.stocktradersdaily.com
The Goldman Sachs Group Has Lowered Expectations for Xenon Pharmaceuticals (NASDAQ:XENE) Stock Price - Defense World
Xenon- A Later Stage Story (NASDAQ:XENE) - Seeking Alpha
Xenon Pharmaceuticals Target of Unusually High Options Trading (NASDAQ:XENE) - Defense World
Q1 EPS Forecast for Xenon Pharmaceuticals Raised by Analyst - Defense World
Xenon Pharmaceuticals: Undervalued Stock with Promising Catalysts and Growth Potential - TipRanks
StockNews.com Downgrades Xenon Pharmaceuticals (NASDAQ:XENE) to Sell - Defense World
XENE stock touches 52-week low at $28.51 amid market shifts By Investing.com - Investing.com South Africa
XENE stock touches 52-week low at $28.51 amid market shifts - Investing.com
JPMorgan Chase & Co. Increases Stock Holdings in Xenon Pharmaceuticals Inc. (NASDAQ:XENE) - Defense World
Prudential Financial Inc. Acquires 24,956 Shares of Xenon Pharmaceuticals Inc. (NASDAQ:XENE) - Defense World
Raymond James Financial Inc. Buys New Position in Xenon Pharmaceuticals Inc. (NASDAQ:XENE) - Defense World
Xenon Pharmaceuticals Looks Attractive Before Epilepsy Data (NASDAQ:XENE) - Seeking Alpha
Xenon Pharmaceuticals to Present Promising Azetukalner Data at AAN 2025 - TipRanks
Xenon Slides Ahead of San Diego Concference - Baystreet.ca
Xenon to Showcase Long-Term 36-Month Azetukalner Data at AAN 2025 - The Manila Times
Breakthrough Epilepsy Drug Shows Remarkable 3-Year Efficacy Data - Stock Titan
Investors Purchase Large Volume of Put Options on Xenon Pharmaceuticals (NASDAQ:XENE) - Defense World
Xenon Pharmaceuticals Enters Oversold Territory (XENE) - Nasdaq
Thrivent Financial for Lutherans Sells 12,394 Shares of Xenon Pharmaceuticals Inc. (NASDAQ:XENE) - Defense World
Xenon Pharmaceuticals Inc. (NASDAQ:XENE) Given Consensus Recommendation of “Buy” by Analysts - Defense World
Teacher Retirement System of Texas Acquires 2,994 Shares of Xenon Pharmaceuticals Inc. (NASDAQ:XENE) - Defense World
11 Best Gene Therapy Stocks to Buy According to Analysts - Insider Monkey
Focal Epilepsy Market: Analysis of Epidemiology, Pipeline - openPR.com
Xenon Pharmaceuticals Inc. (NASDAQ:XENE) Shares Bought by Swiss National Bank - Defense World
(XENE) Trading Advice - news.stocktradersdaily.com
Xenon Pharmaceuticals announces executive changes - MSN
Bank of New York Mellon Corp Sells 2,294 Shares of Xenon Pharmaceuticals Inc. (NASDAQ:XENE) - Defense World
What is William Blair’s Estimate for XENE Q1 Earnings? - Defense World
Xenon Pharmaceuticals at Stifel Forum: Strategic Advances in CNS By Investing.com - Investing.com Canada
0.39%
3.66%
자본화:
|
볼륨(24시간):